Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

被引:57
|
作者
Figlioli, Gisella [1 ]
Landi, Stefano [1 ]
Romei, Cristina [2 ]
Elisei, Rossella [2 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
Medullary thyroid carcinoma; RET gene mutations; RET gene polymorphisms; Meta-analysis; ENDOCRINE NEOPLASIA TYPE-2; CODON; 918; MUTATION; GERMLINE-SEQUENCE VARIANTS; TYROSINE KINASE ACTIVATION; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; MEN; 2A; MULTIVARIATE-ANALYSIS; DISEASE PHENOTYPE; CLINICOPATHOLOGICAL FEATURES;
D O I
10.1016/j.mrrev.2012.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5-10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET protooncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A [rs1800858], G691S [rs1799939], L769L [rs1800861 I, S836S [rs1800862], S904S [rs1800863], and IVS1-126G>T [rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 50 条
  • [41] RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma
    Sisi Wang
    Bo Wang
    Chao Xie
    Daoxiong Ye
    Endocrine Pathology, 2019, 30 : 297 - 304
  • [42] RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma
    Wang, Sisi
    Wang, Bo
    Xie, Chao
    Ye, Daoxiong
    ENDOCRINE PATHOLOGY, 2019, 30 (04) : 297 - 304
  • [43] 27-bp Deletion in the ret proto-oncogene as a somatic mutation associated with medullary thyroid carcinoma
    Kalinin, V
    Frilling, A
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (05): : 365 - 367
  • [44] Mutation of RET proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
    Migita, M
    Hiromatsu, Y
    Sato, M
    Yang, D
    Kameo, J
    Jimi, A
    Nonaka, K
    ENDOCRINE JOURNAL, 1997, 44 (04) : 559 - 565
  • [45] Ret-proto-oncogene analysis in medullary thyroid carcinoma
    O'Keeffe, DA
    Hill, ADK
    Sheahan, K
    Ryan, F
    Barton, D
    Fitzgerald, RJ
    McDermott, EW
    O'Higgins, NJ
    IRISH JOURNAL OF MEDICAL SCIENCE, 1998, 167 (04) : 226 - 230
  • [46] Ret-proto-oncogene analysis in medullary thyroid carcinoma
    D. A. O’Keeffe
    A. D. K. Hill
    E. W. McDermott
    N. J. O’Higgins
    K. Sheahan
    F. Ryan
    D. Barton
    R. J. Fitzgerald
    Irish Journal of Medical Science, 1998, 167 : 226 - 230
  • [47] Prognostic value of codon 918 (ATG→ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
    Schilling, T
    Bürck, J
    Sinn, HP
    Clemens, A
    Otto, HF
    Höppner, W
    Herfarth, C
    Ziegler, R
    Schwab, M
    Raue, F
    INTERNATIONAL JOURNAL OF CANCER, 2001, 95 (01) : 62 - 66
  • [48] Somatic RET proto-oncogene mutations in sporadic C-cell carcinoma of the thyroid
    A. Frilling
    M. Bockhorn
    V. Kalinin
    M. Liedke
    M. Kaun
    C. E. Broelsch
    Der Chirurg, 1997, 68 : 789 - 793
  • [49] Somatic RET proto-oncogene mutations in sporadic C-cell carcinoma of the thyroid
    Frilling, A
    Bockhorn, M
    Kalinin, V
    Liedke, M
    Broelsch, CE
    CHIRURG, 1997, 68 (08): : 789 - 793
  • [50] Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine
    Kumarasamy, Vishnu Muthuraj
    Shin, Yoon-Joo
    White, John
    Sun, Daekyu
    BMC CANCER, 2015, 15